Nancy L.
About Nancy L.
Nancy L. serves as the Executive Vice Chair at EyePoint Pharmaceuticals, having previously held leadership roles at various pharmaceutical companies and advisory boards. She has extensive experience in strategic decision-making, clinical development, and mentoring in the field of medicine.
Work at EyePoint Pharmaceuticals
Currently, Nancy L. serves as the Executive Vice Chair at EyePoint Pharmaceuticals, a position she has held since 2023. Prior to this role, she was the President and Chief Executive Officer from 2016 to 2023. During her tenure, she played a significant role in transforming the company from a research-focused entity into a market leader in retinal eye disease products. She led clinical development efforts, including Phase 2 trials for EYP-1901, and was instrumental in the global launch of key products, achieving substantial revenue growth.
Education and Expertise
Nancy L. holds a Bachelor of Science in Biology from Seattle Pacific University and a Master of Business Administration from the University of Evansville. Her educational background supports her extensive experience in the pharmaceutical and healthcare sectors. She has held various leadership roles, including Senior VP and Chief Marketing Officer at Novartis Pharmaceuticals and Group VP for Global Primary Care Products at Pharmacia Corporation.
Background
Nancy L. has a diverse professional background in the pharmaceutical industry. She began her career as a Senior Medical Representative at Bristol Myers Squibb. Over the years, she has held board positions at several organizations, including Cancer Treatment Centers of America, Mallinckrodt Pharmaceuticals, and Auxilium Pharmaceuticals. Her leadership experience spans both operational and strategic roles in various healthcare companies.
Achievements
Throughout her career, Nancy L. has achieved significant milestones, including leading the global launch of Plavix and Avapro, which generated multi-billion-dollar revenues. She has successfully built investor relations, restructured company debt, and optimized product portfolios. Her contributions to EyePoint Pharmaceuticals included reorganizing pricing strategies and enhancing the company's public profile through strategic marketing initiatives.
Current Advisory Roles
In addition to her role at EyePoint Pharmaceuticals, Nancy L. serves on the Advisory Board for the Stanford School of Medicine's Masters in Translational Research and Applied Medicine program. She also sits on the Advisory Boards for Novo Holdings and Altasciences, where she continues to influence the direction of healthcare innovation and support the development of future leaders in the field.